Cargando…
Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination
Autores principales: | Doss, Alexa, Chen, Rita, Monroy, Jennifer, Wedner, H. James, Kulczycki, Anthony, Dy, Tiffany, Ren, Zhen, Kau, Andrew, Mantia, Tarisa, O'Shaughnessy, Caitlin, Nickles, Brandi, Kendall, Peggy, Diamond, Michael, Zimmerman, Ofer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804479/ http://dx.doi.org/10.1016/j.jaci.2021.12.240 |
Ejemplares similares
-
Immunoglobulin replacement products in current clinical use in the United States have poor neutralizing activity against SARS-CoV-2 Omicron strains
por: Doss, Alexa, et al.
Publicado: (2023) -
mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes
por: Zimmerman, Ofer, et al.
Publicado: (2022) -
SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients
por: Lin, Frank J., et al.
Publicado: (2022) -
The truth about economizing for college: shrinking the college tab
por: O'Shaughnessy, Lynn, et al.
Publicado: (2011) -
Move to strike
por: O'Shaughnessy, Perri
Publicado: (2000)